Fletcher Ws
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 3
-
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Metter Ge (5 shared papers)Grage Tb (3 shared papers)Weiss Aj (3 shared papers)Ping Yein Lee (1 shared paper)Kenneth R. Stevens (1 shared paper)Truman M. Sasaki (1 shared paper)Michelle Harrison (1 shared paper)Nealon Tf (2 shared papers)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (37 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Fletcher Ws
33 papers receiving 452 citations
Peers
Comparison fields: 5 of 71
- Oncology 297
- Pathology and Forensic Medicine 103
- Cardiology and Cardiovascular Medicine 116
- Dermatology 41
- Pulmonary and Respiratory Medicine 134
Countries citing papers authored by Fletcher Ws
This map shows the geographic impact of Fletcher Ws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fletcher Ws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fletcher Ws more than expected).
Fields of papers citing papers by Fletcher Ws
This network shows the impact of papers produced by Fletcher Ws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fletcher Ws. The network helps show where Fletcher Ws may publish in the future.
Co-authors
The 25 scholars most cited alongside Fletcher Ws, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. | 1976 | 110 |
| 2 | Colorectal cancer in young patients: characteristics and outcome. | 1994 | 86 |
| 3 | Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. | 1986 | 48 |
| 4 | Phase II study of 5-azacytidine in solid tumors. | 1977 | 38 |
| 5 | DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). | 1976 | 28 |
| 6 | Regional intra-arterial infusion of adriamycin in the treatment of cancer. | 1977 | 26 |
| 7 | Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. | 1986 | 20 |
| 8 | DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine. | 1980 | 19 |
| 9 | A CLINICAL STUDY OF PRIMARY CARCINOMA OF THE GALLBLADDER. | 1963 | 18 |
| 10 | Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast. | 1974 | 13 |
| 11 | Combination CCNU and bleomycin therapy for squamous cell carcinoma. | 1974 | 12 |
| 12 | Management of chylothorax secondary to lymphoma. | 1972 | 11 |
| 13 | TREATMENT OF CANCER BY BACTERIAL TOXINS. | 1965 | 9 |
| 14 | Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors. | 1988 | 7 |
| 15 | Endocrine ablation and hepatic artery infusion in the treatment of metastases to the liver from carcinoma of the breast. | 1982 | 7 |
| 16 | Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study. | 1982 | 7 |
| 17 | Carcinoma associated with pancreatic cyst. | 1972 | 7 |
| 18 | Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin. | 1976 | 6 |
| 19 | Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.? | 1976 | 6 |
| 20 | Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors. | 1978 | 5 |
About Fletcher Ws
Fletcher Ws is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 38 papers that have together received 518 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Estrogen and related hormone effects (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Research and Treatments (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Oncology (297 citations), Pathology and Forensic Medicine (103 citations), Cardiology and Cardiovascular Medicine (116 citations), Dermatology (41 citations) and Pulmonary and Respiratory Medicine (134 citations). Fletcher Ws has collaborated with scholars based in United States and Canada. Frequent co-authors include Metter Ge, Grage Tb, Weiss Aj, Ping Yein Lee, Kenneth R. Stevens, Truman M. Sasaki, Michelle Harrison, Nealon Tf, Krementz Et and Minton Jp. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.